Probiotic-based Antiviral Solutions for Specialized Environments

Publication ID: 24-11857581_0009_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Probiotic-based Antiviral Solutions for Specialized Environments,” Published Technical Disclosure No. 24-11857581_0009_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857581_0009_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,581.

Summary of the Inventive Concept

This inventive concept adapts antiviral methods and compositions comprising probiotic bacterial molecules for specific, high-need markets, including high-security facilities, disaster relief zones, extreme weather environments, high-density confined spaces, and immune-compromised individuals.

Background and Problem Solved

The original patent disclosed antiviral methods and compositions using probiotic bacterial molecules. However, these solutions were not tailored to address the unique challenges of specialized environments, where the risk of viral infections is heightened. This inventive concept addresses these limitations by providing targeted solutions for these specific markets.

Detailed Description of the Inventive Concept

The inventive concept comprises four key variations: (1) a secure, tamper-evident delivery system for high-security facilities, (2) a composition adapted for extreme weather conditions in disaster relief zones, (3) a portable, ruggedized delivery device for remote, extreme weather environments, and (4) a ventilation system adapted to distribute the composition throughout high-density, confined spaces. These variations leverage the antiviral properties of probiotic bacterial molecules to provide effective solutions for these niche markets.

Novelty and Inventive Step

The new claims introduce novel elements, such as secure delivery systems, weather-resistant compositions, and specialized ventilation systems, which are not present in the original patent. These elements, combined with the probiotic bacterial molecules, provide a non-obvious solution for the specific challenges of these specialized environments.

Alternative Embodiments and Variations

Alternative embodiments could include customized packaging for specific environments, integration with existing infrastructure in high-density spaces, or adaptation of the composition for specific viral strains. These variations would ensure broad conceptual coverage and potential applications in various industries.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in industries such as biotechnology, healthcare, and disaster relief. The targeted solutions for high-security facilities, disaster relief zones, and extreme weather environments could generate significant revenue streams. Additionally, the potential for licensing and partnerships with government agencies, NGOs, and private companies could further expand the market reach.

Original Patent Information

Patent NumberUS 11,857,581
TitleAntiviral methods and compositions comprising probiotic bacterial molecules
Assignee(s)MICROSINTESIS INC.